The Food and Drug Administration (FDA) this week requested that manufacturers of glucagon-like pepti...
Researchers are exploring the potential of glucagon-like peptide 1 (GLP-1) receptor agonists to trea...
Four interventions—metformin and behavioral strategies for weight loss and bupropion and varenicline...
Cholinesterase inhibitors, which are commonly used to treat dementia, may increase the risk of adver...












